SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA's Oncologic Drug Advisory Committee Recommends ChemGenex Pharmaceuticals Limited Validate a Diagnostic Prior to Approval of OMAPRO in Chronic Myeloid Leukemia Patients with T315I Mutation
Your Message